Trio-Tech International Rides AI and EV Testing Demand Into Nasdaq
Trio-Tech International is expected to list on NASDAQ on 2026-09-16, but the company has not disclosed a price range or share count. The bigger story is that this is not a first-time IPO: Trio-Tech is already public and is moving from NYSE American to Nasdaq Global Market. Watch whether investors focus on its AI and EV testing exposure or on the cyclicality and China-related risks.
Trio-Tech International is expected to list on NASDAQ on 2026-09-16, but the company has not disclosed a price range or share count. The bigger story is that this is not a first-time IPO: Trio-Tech is already public and is moving from NYSE American to Nasdaq Global Market. Watch whether investors focus on its AI and EV testing exposure or on the cyclicality and China-related risks.
Quick Facts
Expected listing date: September 16, 2026
Exchange: NASDAQ
Proposed symbol: TRT
Status: Expected
Company Overview
Trio-Tech International (NASDAQ: TRT) is a long-running semiconductor and industrial electronics business founded in 1958. The company is California-based, with executive offices in Singapore and a U.S. corporate office in Van Nuys, California, and it operates across the United States, Singapore, Malaysia, Thailand, and China. Its business is split into Semiconductor Back-End Solutions and Industrial Electronics, and it describes itself as a provider of semiconductor testing services, manufacturing solutions, and value-added distribution services, including reliability test equipment, burn-in testing, and component-, package-, and system-level testing.
The company’s filings frame SBS as the core business, while Industrial Electronics adds a second revenue stream and supports its broader manufacturing and distribution footprint. Management also says it is expanding into medical and gaming-related markets to reduce semiconductor cyclicality and customer concentration. That matters because Trio-Tech is competing in an industry where demand rises and falls with semiconductor capital spending, test specifications, and technology cycles. The company also points to secular demand tied to AI-related chip complexity, EV power devices, and a shift in testing activity toward Southeast Asia, while acknowledging a competitive field with larger rivals and deep-pocketed equipment makers.
Why They're Going Public
The company’s current capital-markets activity is not a classic IPO. Trio-Tech filed a shelf prospectus and later completed a registered direct offering, while also pursuing a listing transfer from NYSE American to Nasdaq Global Market. In the shelf filing, it said proceeds could be used for capital expenditures, possible acquisitions, increasing ownership or buying the remaining equity in partially owned subsidiaries, and general corporate purposes including working capital.
In the April 2026 registered direct offering, Trio-Tech said net proceeds would go to working capital and general corporate purposes. The company raised about $10 million in gross proceeds by selling 1,052,632 shares at $9.50 each. For shareholders, the key unlock is not a brand-new public debut, but a higher-profile Nasdaq listing and a stronger capital base that could support expansion, acquisitions, and subsidiary consolidation.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Trio-Tech’s fiscal 2025 results show a business that is still profitable at the bottom line, but with softer top-line momentum. For the fiscal year ended June 30, 2025, revenue was $36.5 million, down from $42.3 million in fiscal 2024, a decline of about 13.7% year over year. Gross margin was $9.1 million, or 25% of revenue, compared with $10.8 million and 25% the prior year. Net loss attributable to common shareholders was just $41,000, versus net income of $1.1 million in fiscal 2024.
The balance sheet and near-term operating picture look steadier than the headline revenue decline suggests. Trio-Tech reported $19.5 million of cash, cash equivalents, and restricted cash as of June 30, 2025, and backlog of $11.0 million, down from $14.4 million a year earlier. In the first half of fiscal 2026, revenue rebounded to $31.2 million, up 69% year over year, and the company posted $203,000 of net income attributable to common shareholders. Cash, cash equivalents, and restricted cash were $19.2 million as of December 31, 2025.
Risk Factors
The biggest risk is the same one that defines the opportunity: semiconductor cyclicality. Trio-Tech’s results depend on capital spending, customer testing schedules, and technology transitions, so revenue can move sharply when demand slows or customers delay orders. The company also competes in a crowded market where rivals often have greater financial, engineering, manufacturing, and marketing resources, which can pressure pricing and margins.
Investors also need to watch geographic and regulatory exposure. Trio-Tech operates in Asia and the United States, and its filings highlight currency swings, tariffs, local laws, political and economic instability, and PRC-related legal and regulatory uncertainty. The company also flags risks tied to product development, delivery schedules, changes in military or commercial testing specifications, and the loss of key personnel. Lockup terms were not disclosed in the materials reviewed, and the company’s filings say investors could lose all or part of their investment.
Comparable Public Companies
The closest public comps are imperfect, but the most relevant names are Teradyne (TER), Cohu (COHU), Advantest (6857.T / ATEYY), inTEST (INTT), and Amtech Systems (ASYS). Those companies sit in adjacent parts of the semiconductor test and equipment stack, though Trio-Tech is smaller and more mixed, with testing services, manufacturing solutions, and distribution all under one roof. That makes it more of a niche, integrated operator than a pure-play equipment vendor.
I did not pull live valuation multiples for the peer set in this pass, so I can’t responsibly quote current P/E or EV/EBITDA ranges. Directionally, the group is a mixed bag rather than a clean momentum trade: the sector has support from AI and EV demand, but it is still exposed to the same cyclical swings that hit semiconductor capital equipment names. For readers, the key comparison is not just size, but how much of each company’s growth is tied to AI compute, automotive power devices, and broader test-intensity trends versus legacy cyclicality.
Verdict
The setup favors a watchful read rather than a simple IPO verdict, because Trio-Tech is not actually a first-time public listing. The real question is whether the Nasdaq transfer and recent capital raise help re-rate a small, profitable semiconductor testing business that is leaning into AI and EV demand, or whether investors stay focused on the company’s cyclicality, Asia exposure, and modest scale. The market-timing angle is real: semiconductor test names can get attention when AI and EV narratives are strong, but this is still a niche operator with a long operating history, not a fresh venture-style growth story.
What shareholders should watch as it prices is whether the market treats Trio-Tech as a steady niche infrastructure name or as a cyclical small-cap with uneven revenue. The company’s first-half fiscal 2026 rebound, $19.2 million cash balance, and $11.0 million backlog give it a better near-term setup than the fiscal 2025 headline decline suggests. But the absence of disclosed IPO-style pricing, share count, and lockup terms means the key signal will be how investors react to the Nasdaq transfer and the company’s AI/EV testing narrative versus its competitive and geographic risks.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
